You can rely on our pharmaceutical industry experience and our resources to streamline your time to market while cutting cost and increasing efficiency.
By embracing High Content Biology at an early stage in the drug discovery pipeline, you will gain a wealth of information relating both on-target specificity and off-target toxicity. This allows you to better predict how the compound will ultimately behave in a clinical setting.
Why use Imagen Biotech?
- Complete flexibility over assay design and plate layout
- Large number of fully validated assays and deep expertise in assay development
- Rapid turnaround
- Successful track record